Banna, Giuseppe Luigi http://orcid.org/0000-0003-0764-3650
Friedlaender, Alex
Tagliamento, Marco
Mollica, Veronica
Cortellini, Alessio
Rebuzzi, Sara Elena
Prelaj, Arsela
Naqash, Abdul Rafeh
Auclin, Edouard
Garetto, Lucia
Mezquita, Laura
Addeo, Alfredo
Article History
Accepted: 16 September 2022
First Online: 18 October 2022
Declarations
:
: G.L.B. reports personal fees from AstraZeneca, Astellas, travel and conference expenses from Janssen. A.F. reports personal fee from BMS, MSD, Astellas, Pfizer, Janssen, Roche, Boehringer Ingelheim, GSK, Bayer, outside the submitted work. M.T. reports personal fees from Novartis, Amgen, MSD, travel and conference expenses from Roche, BMS, Takeda, AstraZeneca, Eli Lilly. A.C. reports personal fees rom Roche, Astrazeneca, Novartis, MSD, BMS, EISAI, outside the submitted work. A.P. reports personal fees from Bristol Myers Squibb, AstraZeneca, Italfarma, grants from Roche, outside the submitted work. E.A. reports personal fees from Amgen, Sanofi, grants from Nuovo Soldati, outside the submitted work. L.M.: Research grant/Funding (self): Bristol Myers Squibb, Boehringer Ingelheim, Amgen, Stilla, Inivata; Advisory/Consultancy: Roche, Takeda; Honoraria (self): Bristol Myers Squibb, Takeda, Roche, AstraZeneca; Travel/Accommodation/Expenses: Bristol Myers Squibb, Takeda, Roche, AstraZeneca; Non-remunerated activity/ies: AstraZeneca. A.A. reports grants, personal fees and non-financial support from Bristol Myers Squibb, grants from Boehringer Ingelheim, Amgen, Stilla, Inivata, personal fees and non-financial support from Roche, Takeda, AstraZeneca, outside the submitted work. All the other authors report no disclosures.